HCP
BIIB icon

Hexagon Capital Partners’s Biogen BIIB Stock Holding History

Hexagon Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19
Closed -$2.6K – 261
2025
Q1 		$2.6K Sell
19
-18
-49% -$2.57K ﹤0.01% 1333
2024
Q4 		$5.66K Sell
37
-7
-16% -$1.18K ﹤0.01% 1174
2024
Q3 		$8.53K Sell
44
-1
-2% -$209 ﹤0.01% 961
2024
Q2 		$10.4K Sell
45
-6
-12% -$1.3K ﹤0.01% 865
2024
Q1 		$11K Sell
51
-67
-57% -$15.7K ﹤0.01% 837
2023
Q4 		$30.5K Buy
118
+51
+76% +$12.5K 0.01% 523
2023
Q3 		$17.2K Sell
67
-24
-26% -$6.42K ﹤0.01% 597
2023
Q2 		$25.9K Buy
91
+3
+3% +$893 0.01% 497
2023
Q1 		$24.5K Sell
88
-8
-8% -$2.21K 0.01% 495
2022
Q4 		$26.6K Sell
96
-89
-48% -$25.1K 0.01% 475
2022
Q3 		$49K Sell
185
-34
-16% -$7.22K 0.01% 391
2022
Q2 		$45K Buy
219
+50
+30% +$10.2K 0.01% 383
2022
Q1 		$36K Sell
169
-8
-5% -$1.74K 0.01% 412
2021
Q4 		$42K Hold
177
– – 0.01% 385
2021
Q3 		$50K Hold
177
– – 0.01% 345
2021
Q2 		$61K Hold
177
– – 0.02% 301
2021
Q1 		$49K Hold
177
– – 0.01% 309
2020
Q4 		$43K Hold
177
– – 0.01% 284
2020
Q3 		$44K Buy
+177
New +$49.4K 0.01% 269

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hexagon Capital Partners's BIIB Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Biogen (BIIB) in Q2 2025, closing a stake of 19 shares — an estimated $2.6K sold.

Hexagon Capital Partners first reported a position in BIIB in Q3 2020 and held it in 19 quarters. The position peaked at $61K in Q2 2021. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 19 Biogen shares in Q2 2025, an estimated $2.6K.
  • Hexagon Capital Partners first reported a position in Biogen in Q3 2020 and held it in 19 quarters.
  • Hexagon Capital Partners's Biogen position peaked at $61K in Q2 2021.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.